Hyposecretion of the adrenal androgen dehydroepiandrosterone sulfate and its relation to clinical variables in inflammatory arthritis

Arthritis Research

Volumn 3, Issue 3, 2001, Pages 183-188

  Dessein, Patrick H ^a   Joffe, Barry I ^a   Stanwix, Anne E ^a   Moomal, Zubair ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b NATIONAL RESEARCH FOUNDATION   (South Africa)

Author keywords

Dehydroepiandrosterone sulfate; Inflammatory arthritis

Indexed keywords

ALENDRONIC ACID; AMITRIPTYLINE; ANDROGEN; CLONAZEPAM; CYTOKINE; GLUCOCORTICOID; GLUCOSE; INSULIN; LANSOPRAZOLE; LIPID; METHOTREXATE; MIANSERIN; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE AGONIST; PARACETAMOL; PRASTERONE SULFATE; SALAZOSULFAPYRIDINE; STEROID HORMONE;

ADRENAL DISEASE; ADULT; AGED; ANDROGEN RELEASE; ARTHRITIS; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HORMONE RELEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PATHOPHYSIOLOGY; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; SPONDYLOARTHROPATHY; TREATMENT INDICATION; TREATMENT PLANNING;

ADOLESCENT; ADRENAL GLANDS; ADRENAL INSUFFICIENCY; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; BLOOD GLUCOSE; BLOOD SEDIMENTATION; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; SPONDYLITIS, ANKYLOSING;

EID: 0035048204     PISSN: 14659905     EISSN: None     Source Type: Journal    
DOI: 10.1186/ar296     Document Type: Article

References (31)

1. Recent aspects of gonadal hormone and neurotransmitter interactions with synovial and immune cells: Implications in rheumatoid arthritis
2. Enigmas of adrenal androgen and glucocorticoid dissociation in premenopausal onset rheumatoid arthritis
3. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease
4. Hypothalamic-pituitary-adrenal-glucocorticoid axis function in rheumatoid arthritis
5. Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids
6. Decreased serum dehydroepiandrosterone sulfate levels in menstruating women prior to onset of RA before age 50: Independent reference laboratory assays validate previous significant results
7. Perturbations of hypothalamic-pituitary-gonadal axis and adrenal androgen functions in rheumatoid arthritis: An odyssey of hormonal relationships to the disease
8. Serum androgen-anabolic hormones and the risk of rheumatoid arthritis
9. Relationship between blood and joint tissue DHEAS levels in rheumatoid arthritis and osteoarthritis
10. Should dehydroepiandrosterone replacement therapy be provided with glucocorticoids?
11. Abnormal hypothalamic-pituitary-adrenal axis function in rheumatoid arthritis. Effects of non-steroidal antiinflammatory drugs and water immersion
12. Impaired glucose handling in active rheumatoid arthritis: Relationship to peripheral insulin resistance
13. Stress-related cortisol secretion in men: Relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities
14. The american rheumatology association 1987 revised criteria for the classification of rheumatoid arthritis
15. A wider spectrum of spondyloarthropathies
16. Prevalence of insulin resistance in metabolic disorders
17. Low dose amytriptyline in ankylosing spondylitis. A short term, double-blind placebo controlled study
18. Low blood and synovial fluid levels of sulpho-conjugated steroids in rheumatoid arthritis
19. Androgens and ankylosing spondylitis: A role in the pathogenesis?
20. Serum levels of dehydroepiandrosterone (DHEA-S) in ankylosing spondylitis
21. Early inflammatory polyarthritis: Results from the Norfolk Arthritis register with a review of the literature. I. Risk factors for the development of inflammatory polyarthritis and rheumatoid arthritis
22. Sex hormone status of male patients with rheumatoid arthritis: Evidence of low serum concentrations of testosterone at baseline and after human chorionic gonatotropin stimulation
23. Age-related decrease of dehydroepiandrosterone concentrations in low density lipoproteins and its role in the susceptibility of low density lipoproteins to lipid peroxidation
24. Death rate and causes of death in RA patients during a period of five years
25. Ten year mortality and causes of death in patients with rheumatoid arthritis
26. Rheumatoid arthritis and mortality. A longitudinal study in Pima Indian
27. Rheumatoid arthritis and cardiovascular disease may share similar risk factors
28. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age
29. Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months
30. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women
31. Dehydroepiandrosterone replacement in women with adrenal insufficiency